IAA
TEVA icon

Independent Advisor Alliance’s Teva Pharmaceuticals TEVA Stock Holding History

Independent Advisor Alliance’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,021
Closed -$117K – 705
2021
Q3 		$117K Buy
+12,021
New +$113K 0.01% 603
2021
Q1 		– Sell
-10,370
Closed -$100K – 650
2020
Q4 		$100K Buy
10,370
+150
+1% +$1.44K 0.01% 529
2020
Q3 		$92K Sell
10,220
-2,500
-20% -$26.4K 0.01% 477
2020
Q2 		$157K Sell
12,720
-415
-3% -$4.69K 0.02% 450
2020
Q1 		$118K Buy
+13,135
New +$135K 0.02% 387
2017
Q3 		– Sell
-6,616
Closed -$206K – 279
2017
Q2 		$206K Buy
+6,616
New +$205K 0.07% 229

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Independent Advisor Alliance's TEVA Position: Q4 2021 in Review

Independent Advisor Alliance sold out of Teva Pharmaceuticals (TEVA) in Q4 2021, closing a stake of 12,021 shares — an estimated $117K sold.

Independent Advisor Alliance first reported a position in TEVA in Q2 2017 and held it in 6 quarters. The position peaked at $206K in Q2 2017. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • Independent Advisor Alliance reported no remaining Teva Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Independent Advisor Alliance sold 12,021 Teva Pharmaceuticals shares in Q4 2021, an estimated $117K.
  • Independent Advisor Alliance first reported a position in Teva Pharmaceuticals in Q2 2017 and held it in 6 quarters.
  • Independent Advisor Alliance's Teva Pharmaceuticals position peaked at $206K in Q2 2017.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2021.

Based on Independent Advisor Alliance's 13F filing for Q4 2021, filed 11 Feb 2022.